Want to join the conversation?
$MU said that DRAM revenue rose 9% in 3Q16 vs. 2Q16, due to the 22% increase in bit shipments, partially offset by lower selling prices. The company's Non-Volatile Trade revenue fell 15% vs. 2Q16, representing 10% decrease in bit shipments combined with 6% decrease in ASPs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.